Angel Groups

Growth-stage tech companies, ~$200K-$1M raise. Sweet spots: SaaS, life sciences, IoT, agtech, advanced materials, hardware.

Software startups with early sales traction (~$100K ARR target). Uses Dealum for applications.

Early-stage companies with developed product and early customer traction. $25K-$250K checks. SaaS focus preferred, also healthcare and consumer products.

SaaS, fintech, B2B/B2C tech, CPG, healthcare and services companies. Valuations typically $3M-$20M.

New Mexico-based companies preferred, or those with clear NM economic impact. Sector-agnostic; bioscience, aerospace, tech, healthcare are top categories.

Early-stage B2B SaaS/AI companies, pre-seed through seed-plus. Checks $300K-$1M.

Post-revenue, faith-driven founders who integrate Christian mission into their business. Does not fund pre-revenue or concept-stage companies.

Early-stage IT, med tech, and green tech companies. Checks roughly $200K. Want scalable models with 3-5 year exit path.

Early-stage companies across tech, life sciences, and SaaS. Minimum investment around $10K per angel; deals often total $200K-$250K.

Early-stage healthcare companies: medical devices, diagnostics, biotech, digital health. Checks $200K-$800K.

Technology-centric or low-tech execution-driven businesses needing $3M or less to reach meaningful 3-year revenue milestones, with a 3-5 year path to a liquidity event. No revenue minimum, has funded $0 to $3M ARR companies.

Companies with $750K+ in revenue traction (or approaching clinical trials for life sciences / TRL 6-7 for tech), prior angel fundraising experience, and a defined capital raise budget.

Early-stage tech and life science companies, pre-seed through Series A, with an MVP and early customer traction. Checks $500K-$2M.